Who is sponsoring NCT00161798?

NCT00161798 is sponsored by Pfizer.

What condition does NCT00161798 study?

NCT00161798 studies Tick-borne Encephalitis.

What drugs are being tested in NCT00161798?

Interventions: Tick-borne encephalitis vaccine.

What is the status of NCT00161798?

NCT00161798 is currently COMPLETED.

Last reviewed 2015-05-20 · How we verify

Double-blind, Randomized, Multicenter Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

NCT00161798 Phase 2 COMPLETED

The purpose of this study is to investigate the safety and immunogenicity of three different concentrations of a TBE vaccine will be investigated in healthy children aged 6 to 16 years.

Details

Lead sponsor	Pfizer
Phase	Phase 2
Status	COMPLETED
Start date	2001-09
Completion	2002-03

Conditions

Tick-borne Encephalitis

Interventions

Tick-borne encephalitis vaccine

Countries

Germany